Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | PTGER4 | P35408 | 3/20 | 0.54 |
| ▸ | PTGER3 | P43115 | 3/20 | 0.54 |
| ▸ | PTGER2 | P43116 | 3/20 | 0.54 |
| ▸ | PTGER1 | P34995 | 2/20 | 0.54 |
| ▸ | THRA | P10827 | 1/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.50 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.49 |
| ▸ | FPR1 | P21462 | 1/20 | 0.49 |
| ▸ | FPR3 | P25089 | 1/20 | 0.49 |
| ▸ | GPR183 | P32249 | 1/20 | 0.49 |
| ▸ | APLNR | P35414 | 1/20 | 0.49 |
| ▸ | GPR65 | Q8IYL9 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29843936 | 1.00 | NPSR1 (0.61) | NPSR1PTGER4PTGER3PTGER2PTGER1 | |
| Water SCHEMBL10936872 | 0.98 | NPSR1 (0.59) | NPSR1PTGER4PTGER3PTGER2PTGER1 | |
| Hydrochloric Acid SCHEMBL16238973 | 0.98 | NPSR1 (0.59) | NPSR1PTGER4PTGER3PTGER2PTGER1 | |
| Dimethylamine SCHEMBL8072827 | 0.89 | FFAR1 (0.51) | NPSR1PTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL3673001 | 0.88 | HDAC3 (0.57) | NPSR1PTGER4PTGER3PTGER2PTGER1 | |
| Dimethylamine SCHEMBL8072928 | 0.88 | FFAR1 (0.50) | NPSR1PTGER4PTGER3PTGER2PTGER1 | |
| Cyclopentanone SCHEMBL27320194 | 0.87 | NPSR1 (0.47) | NPSR1PTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL4253986 | 0.86 | MAPT (0.56) | PTGER4PTGER3PTGER2PTGER1TAAR1 | |
| SCHEMBL9863165 | 0.86 | HDAC3 (0.55) | NPSR1PTGER4PTGER3PTGER2PTGER1 | |
| SCHEMBL9863168 | 0.86 | HDAC3 (0.55) | NPSR1PTGER4PTGER3PTGER2PTGER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 429 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-20250017950-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | UCL BUSINESS LTD (GB) | 2025-01-16 | — | — | US | claimed |
| EP-4433077-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | UCL Business Ltd (GB) | 2024-09-25 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-117106189-A | Metal organic framework artificial hydrolase and preparation method and application thereof | 华南理工大学 | 2023-11-24 | — | — | CN | claimed |
| WO-2023089313-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | UCL BUSINESS LTD (GB) | 2023-05-25 | — | — | WO | claimed |
| EP-3830233-A1 | STABILIZED COMPOSITIONS COMPRISING LEUCO COMPOUNDS | Milliken & Company (US) | 2021-06-09 | — | — | EP | claimed |
| WO-2020023897-A1 | STABILIZED COMPOSITIONS COMPRISING LEUCO COMPOUNDS | MILLIKEN & COMPANY (US) | 2020-01-30 | — | — | WO | claimed |
| CN-106893048-B | A kind of preparation method of polycarboxylic acids dehydragent | 上海台界化工有限公司 | 2019-04-02 | — | — | CN | claimed |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-11 | — | — | US | claimed |
| US-20090312216-A1 | Photoresist Stripper Composition for Semiconductor Manufacturing | TECHNO SEMICHEM CO., LTD. (KR) | 2009-12-17 | — | — | US | claimed |
| EP-1913448-A4 | PHOTORESIST STRIPPER COMPOSITION FOR SEMICONDUCTOR MANUFACTURING | TECHNO SEMICHEM CO LTD (KR) | 2008-11-05 | — | — | EP | claimed |
| EP-1913448-A1 | PHOTORESIST STRIPPER COMPOSITION FOR SEMICONDUCTOR MANUFACTURING | Techno Semichem Co., Ltd. (KR) | 2008-04-23 | — | — | EP | claimed |
| WO-2007021085-A1 | PHOTORESIST STRIPPER COMPOSITION FOR SEMICONDUCTOR MANUFACTURING | TECHNO SEMICHEM CO., LTD. (KR) | 2007-02-22 | — | — | WO | claimed |
| US-20060127681-A1 | Method for coating metallic surfaces with a silane-rich composition | CHEMETALL GMBH (DE) | 2006-06-15 | — | — | US | claimed |
| US-20060099429-A1 | Method for coating metallic surfaces with a composition that is rich in polymers | CHEMETALL GMBH (DE) | 2006-05-11 | — | — | US | claimed |
| US-6893687-B2 | Wetting with aqueous dispersion containing ultraviolet radiation crosslinkable resin, photoinitiator, corrosion inhibitor and wax; drying and curing without cracking or flaking | CHEMETALL GMBH (DE) | 2005-05-17 | — | — | US | claimed |
| US-20040022951-A1 | Method for coating metallic surfaces and use of substrates coated in such a way or coatings produced in such a way | CHEMETALL GMBH (DE) | 2004-02-05 | — | — | US | claimed |
| US-20030185990-A1 | Method for pretreating and coating metal surfaces prior to forming, with a paint-like coating and use of substrates so coated | CHEMETALL GMBH (DE) | 2003-10-02 | — | — | US | claimed |
| US-6451334-B2 | PULSE ADMINISTERING OF A C1-C4 SUBSTITUTED AND/OR PHENYL SUBSTITUTED CARBOXYLIC ACID AND SALTS AND A CARRIER OR DILUENT TO STIMULATE CELLS IN TREATING BLOOD DISORDERS, E.G. SICKLE CELL ANEMIA, THALASSEMIA, BLOOD LOSS ETC. | Perrine, Susan P. | 2002-09-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | PTPRCAP, PTPRF, PTPRS | NPSR1 3502/4885PTGER4 4364/4885PTGER3 4461/4885 |
| US-20250017950-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | POLRMT, TK2, GOT2 | NPSR1 4857/4885PTGER4 4444/4885PTGER3 4381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.